KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Work In Process (2018 - 2025)

Globus Medical (GMED) has disclosed Work In Process for 8 consecutive years, with $63.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Work In Process rose 46.12% year-over-year to $63.7 million, compared with a TTM value of $63.7 million through Sep 2025, up 46.12%, and an annual FY2024 reading of $45.8 million, up 22.65% over the prior year.
  • Work In Process was $63.7 million for Q3 2025 at Globus Medical, up from $60.4 million in the prior quarter.
  • Across five years, Work In Process topped out at $63.7 million in Q3 2025 and bottomed at $16.8 million in Q2 2021.
  • Average Work In Process over 5 years is $31.3 million, with a median of $23.6 million recorded in 2023.
  • The sharpest move saw Work In Process dropped 18.8% in 2021, then soared 101.93% in 2023.
  • Year by year, Work In Process stood at $17.4 million in 2021, then increased by 7.46% to $18.7 million in 2022, then surged by 99.59% to $37.3 million in 2023, then grew by 22.65% to $45.8 million in 2024, then surged by 39.11% to $63.7 million in 2025.
  • Business Quant data shows Work In Process for GMED at $63.7 million in Q3 2025, $60.4 million in Q2 2025, and $48.0 million in Q1 2025.